Osaic Holdings’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Osaic Holdings’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,500	Closed	-$613	–	7510
2023 Q3	$613	Buy	3,500 +2,000	+133%	+$2.48K	﹤0.01%	6950
2023 Q2	$4.68K	Buy	+1,500	New	+$4.46K	﹤0.01%	6351
2022 Q3	–	Sell	-107	Closed	–	–	7586
2022 Q2	$0	Hold	107	–	–	﹤0.01%	7672
2022 Q1	$0	Sell	107 -1,451	-93%	-$3.78K	﹤0.01%	7601
2021 Q4	$7K	Buy	1,558 +346	+29%	+$1.14K	﹤0.01%	6504
2021 Q3	$10K	Sell	1,212 -791	-39%	-$6.78K	﹤0.01%	6223
2021 Q2	$20K	Buy	2,003 +1,490	+290%	+$12.1K	﹤0.01%	5672
2021 Q1	$5K	Buy	+513	New	+$5.63K	﹤0.01%	6195

Other funds holding GRTX

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings's GRTX Position: Q4 2023 in Review

Osaic Holdings sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2023, closing a stake of 3,500 shares — an estimated $613 sold.

Osaic Holdings first reported a position in GRTX in Q1 2021 and held it in 8 quarters. The position peaked at $20K in Q2 2021. 37 funds tracked by Wall St. Rank hold GRTX as of Q4 2023.

Osaic Holdings reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Osaic Holdings sold 3,500 Galera Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $613.
Osaic Holdings first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Osaic Holdings's Galera Therapeutics, Inc. Common Stock position peaked at $20K in Q2 2021.
37 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Osaic Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.